news
Statins linked to lower glaucoma risk, fewer surgeries
New research shows people taking statins were 15% less likely to develop open-angle glaucoma over five years. For those who already had glaucoma, statin use meant significantly lower rates of eye surgery and laser treatments. This suggests a systemic effect on eye health beyond just cholesterol management.
New research shows people taking statins were 15% less likely to develop open-angle glaucoma over five years. For those who already had glaucoma, statin use meant significantly lower rates of eye surgery and laser treatments. This suggests a systemic effect on eye health beyond just cholesterol management.
The architecture take
The takeaway here isn't just about cholesterol or heart disease, it's about inflammation and how that buzzes through your entire system — including your eyes. I've often thought of statins as a very specific drug for a very specific problem, but this research keeps hinting at broader anti-inflammatory properties that could be a systemic win. It's almost like a downstream effect of dampening chronic inflammation could protect your nervous system in unexpected ways, even the delicate parts like the optic nerve. This study, appearing in Ophthalmology, looked at over 150,000 people. It makes me wonder what other long-term, low-grade inflammatory conditions could be mitigated by the same mechanisms. It's a reminder that the body's systems don't operate in a vacuum.